714 related articles for article (PubMed ID: 27787452)
21. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
22. USE OF FEMORAL ARTERY ULTRASOUND DURING INTRAARTERIAL CHEMOTHERAPY FOR CHILDREN UNDER 10 KG WITH RETINOBLASTOMA.
Kim RS; Dannenbaum MJ; Lin MW; Bretana ME; Brown DL; Schefler AC
Retina; 2018 Jul; 38(7):1420-1426. PubMed ID: 28541962
[TBL] [Abstract][Full Text] [Related]
23. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
24. Rhegmatogenous retinal detachment following treatment for retinoblastoma.
Saumya Pal S; Gopal L; Khetan V; Nagpal A; Sharma T
J Pediatr Ophthalmol Strabismus; 2010; 47(6):349-55. PubMed ID: 20055334
[TBL] [Abstract][Full Text] [Related]
25. Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma.
Kotlyar B; Shapiro M; Blair M
Ophthalmic Surg Lasers Imaging Retina; 2019 Apr; 50(4):248-252. PubMed ID: 30998248
[TBL] [Abstract][Full Text] [Related]
26. Retinoblastoma vascular perfusion and intra-arterial chemotherapy cycle requirements.
Lim LS; Dalvin LA; Ancona-Lezama D; Yu MD; Jabbour P; Shields CL
Clin Exp Ophthalmol; 2019 Dec; 47(9):1164-1172. PubMed ID: 31432625
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
28. Rhegmatogenous Retinal Detachment after Intravitreal Injection.
Brown KR; Yannuzzi NA; Smiddy WE; Gregori NZ; Berrocal AM; Haddock LJ; Schwartz SG; Lee WH; Sridhar J; Wu DM; Flynn HW; Townsend JH
Ophthalmol Retina; 2021 Feb; 5(2):178-183. PubMed ID: 32673672
[TBL] [Abstract][Full Text] [Related]
29. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Rojanaporn D; Chanthanaphak E; Boonyaopas R; Sujirakul T; Hongeng S; Ayudhaya SSN
Asia Pac J Ophthalmol (Phila); 2019; 8(3):211-217. PubMed ID: 30714357
[TBL] [Abstract][Full Text] [Related]
30. CLINICAL PRESENTATIONS AND OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENT IN RETINITIS PIGMENTOSA.
Dave VP; Jalali S; Nayaka A; Pappuru RR; Pathengay A; Das T
Retina; 2016 Jul; 36(7):1345-8. PubMed ID: 26655616
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
[TBL] [Abstract][Full Text] [Related]
32. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
33. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Stacey AW; De Francesco S; Borri M; Hadjistilianou T
Ophthalmol Retina; 2021 Aug; 5(8):824-830. PubMed ID: 33221516
[TBL] [Abstract][Full Text] [Related]
34. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
Rishi P; Sharma T; Sharma M; Maitray A; Dhami A; Aggarwal V; Munusamy S; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2017 Apr; 65(4):311-315. PubMed ID: 28513496
[TBL] [Abstract][Full Text] [Related]
35. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
36. Anatomical and visual outcomes after episcleral macular buckling compared with those after pars plana vitrectomy for retinal detachment caused by macular hole in highly myopic eyes.
Ando F; Ohba N; Touura K; Hirose H
Retina; 2007 Jan; 27(1):37-44. PubMed ID: 17218913
[TBL] [Abstract][Full Text] [Related]
37. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
38. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
39. Surgical repair of rhegmatogenous retinal detachment in eyes harboring active retinoblastoma.
Yousef YA; Manna M; Khalil MB; Nawaiseh I
Ophthalmic Genet; 2016 Sep; 37(3):314-7. PubMed ID: 26849063
[TBL] [Abstract][Full Text] [Related]
40. Microscope-Assisted ab externo Surgery for the Treatment of Primary Rhegmatogenous Retinal Detachment - New Tech Meets Old Art.
Frisina R; Forlini M; Date P; Meduri A; Pinackatt JS; Sborgia L; Besozzi G; Parolini B
Ophthalmic Res; 2020; 63(1):34-40. PubMed ID: 31352453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
